This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Texas Institute For Surgery Physicians Take Podium At Aesthetic Meeting

DALLAS, April 1, 2013 /PRNewswire/ -- Four surgeons on the medical staff of Texas Institute for Surgery will share their expertise with plastic surgeons at the American Society for Aesthetic Plastic Surgery's (ASAPS) 46 th Annual Meeting this month.

(Photo: http://photos.prnewswire.com/prnh/20130401/DA86351-a)

(Photo: http://photos.prnewswire.com/prnh/20130401/DA86351-b)

(Photo: http://photos.prnewswire.com/prnh/20130401/DA86351-c)

Surgical leaders Drs. C. Spencer Cochran, Jack Gunter, Harlan Pollock and Todd Pollock will present to the world's foremost aesthetic surgeons across April 11-16 in New York City.  The meeting highlights the latest news, technologies, and trends in cosmetic surgery of the face and the entire body.

Nearly 2,000 U.S. and international surgeons will gather for the four-day symposium at the Jacob K. Javits Convention Center, according to meeting organizers. The forum allows surgeons the chance to connect, improve patient safety, and discuss the practices that define their specialties.

Dallas-based Texas Institute for Surgery (TIS) is home to a number of surgeons with distinguished reputations, according to president David Helfer, FACHE. "The fact that both patients and peers recognize the expertise of our surgeons keeps us mindful of exceeding expectations in surgery, and via contributions to a complex field."

Dr. Cochran will present a two-hour course, "Improving Results in Rhinoplasty."  The course is designed to assess how to decrease revisionary rhinoplasty rates, and to develop a comprehensive plan to address aesthetic and functional nasal deformities.

"Rhinoplasty intrigues me because of its inherent degree of difficulty," Dr. Cochran said. "To be extraordinary, you must develop a keen aesthetic eye, a deep understanding of anatomy, and incredible technical proficiency. You must also commit to it as a specialty because rhinoplasty is a procedure that is challenging to do well if you are not doing it all the time."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs